Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

Clinical Gastroenterology and Hepatology

Volumn 3, Issue 2, 2005, Pages 167-174

  Naveau, Sylvie ^a   Raynard, Bruno ^a   Ratziu, Vlad ^b   Abella, Annie ^a   Imbert Bismut, Françoise ^b   Messous, Djamila ^b   Beuzen, Fabienne ^a   Capron, Frédérique ^a   Thabut, Dominique ^b   Munteanu, Mona ^b   Chaput, Jean Claude ^a   Poynard, Thierry ^b  

^a Hop Antoine Beclere ^*  (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN; HYALURONIC ACID;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOLISM; AREA UNDER THE CURVE; ARTICLE; ASCITES; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM HEMORRHAGE; DRINKING BEHAVIOR; ESOPHAGUS VARICES; FEMALE; HUMAN; HUMAN TISSUE; JAUNDICE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PREDICTION; PROSPECTIVE STUDY; RATING SCALE; ROC CURVE; SCORING SYSTEM; SERUM; STANDARD;

BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 12344335496     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(04)00625-1     Document Type: Article

References (53)

1. G. Arteel, L. Marsano, C. Mendez Advances in alcoholic liver disease Best Pract Res Clin Gastroenterol 17 2003 625 647
2. A.M. Diehl Liver disease in alcohol abusers clinical perspective Alcohol 27 2002 7 11
3. H. Gordon Detection of alcoholic liver disease World J Gastroenterol 7 2001 297 302
4. S. Sussman, C.W. Dent, S. Skara Alcoholic liver disease (ALD) a new domain for prevention efforts Subst Use Misuse 37 2002 1887 1904
5. T.N. Chikritzhs, H.A. Jonas, T.R. Stockwell Mortality and life-years lost due to alcohol a comparison of acute and chronic causes Med J Aust 174 2001 281 284
6. K.V. Menon, G.J. Gores, V.H. Shah Pathogenesis, diagnosis, and treatment of alcoholic liver disease Mayo Clin Proc 76 2001 1021 1029
7. S.L. Friedman, J.J. Maher, D.M. Bissell Mechanisms and therapy of hepatic fibrosis report of the AASLD Single Topic Basic Research Conference Hepatology 32 2000 1403 1408
8. D.B. McGill, J. Rakela, A.R. Zinsmeister A 21-year experience with major hemorrhage after percutaneous liver biopsy Gastroenterology 99 1990 1396 1400
9. T. Poynard, V. Ratziu, P. Bedossa Appropriateness of liver biopsy Can J Gastroenterol 14 2000 543 548
10. J.F. Cadranel, P. Rufat, F. Degos Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF) Hepatology 32 2000 477 481
11. T. Poynard, A. Aubert, P. Bedossa A simple biological index for detection of alcoholic liver disease in drinkers Gastroenterology 100 1991 1397 1402
12. F. Oberti, E. Valsesia, C. Pilette Noninvasive diagnosis of hepatic fibrosis or cirrhosis Gastroenterology 113 1997 1609 1616
13. S. Naveau, T. Poynard, C. Benattar Alpha-2-macroglobulin and hepatic fibrosis. Diagnostic interest Dig Dis Sci 39 1994 2426 2432
14. C. Fabris, E. Falleti, E. Federico A comparison of four serum markers of fibrosis in the diagnosis of cirrhosis Ann Clin Biochem 34 1997 151 155
15. M. Tsutsumi, S. Takase, S. Urashima Serum markers for hepatic fibrosis in alcoholic liver disease which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase? Alcohol Clin Exp Res 20 1996 1512 1517
16. A. Robert, O. Chazouillères Prothrombin time in liver failure time, ratio, activity percentage, or international normalized ratio? Hepatology 24 1996 1392 1394
17. T. Poynard, F. Imbert-Bismut, V. Ratziu Serum markers of liver fibrosis Hepatology Rev 1 2004 25 33
18. F. Imbert-Bismut, V. Ratziu, L. Pieroni Biochemical markers of liver fibrosis in patients with hepatitis C virus infection a prospective study Lancet 357 2001 1069 1075
19. T. Poynard, F. Imbert-Bismut, V. Ratziu Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. The GERMED cyt-04 group J Viral Hepat 9 2002 128 133
20. R.P. Myers, V. Ratziu, F. Imbert-Bismut Biochemical markers of liver fibrosis a comparison with historical features in patients with chronic hepatitis C Am J Gastroenterol 97 2002 2419 2425
21. R.P. Myers, Y. Benhamou, F. Imbert-Bismut Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus-coinfected patients AIDS 17 2003 1 5
22. R.P. Myers, M. de Torres, F. Imbert-Bismut Biochemical markers of fibrosis in patients with chronic hepatitis C a comparison with prothrombin time, platelet count and the age-platelet index Dig Dis Sci 48 2003 146 153
23. T. Poynard, J. McHutchison, M. Manns Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin Hepatology 38 2003 481 492
24. P. Halfon, F. Imbert-Bismut, D. Messous A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease Comp Hepatol 1 2002 3 7
25. F. Imbert-Bismut, D. Messous, V. Thibaut Intralaboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors Clin Chem Lab Med 42 2004 323 333
26. M. Munteanu, D. Messous, D. Thabut Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (Fibrotest) and activity (Actitest) Comp Hepatol 3 2004 3
27. T. Poynard, M. Munteanu, F. Imbert-Bismut Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C Clin Chem 50 2004 1344 1355
28. R.P. Myers, M.H. Tainturier, V. Ratziu Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B J Hepatol 39 2003 222 230
29. E. Rossi, L. Adams, A. Prins Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients Clin Chem 49 2003 450 454
30. Poynard T, Imbert-Bismut F, Ratziu V, et al. Fibrotest even better than liver biopsy? Clin Chem 2003. Electronic letter. Available at: www.clinchem.org/cgi/eletters/49/3/450. Response: (21 March 2003). Accessed December 17, 2004.
31. P. Halfon, M. Bourliere, R. Deydier Independent prospective multicentre validation of biochemical markers (FibroTest-ActiTest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C (abstr) Hepatology 38 2003 188A
32. N. Callewaert, H. Van Vlierberghe, A. Van Hecke Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics Nat Med 10 2004 1 6
33. G. Borroni, M. Cazzaniga, R. Ceriani Comparison of usefulness and accuracy of simple noninvasive models as predictors of cirrhosis in chronic hepatitis (abstr) J Hepatol 40 2004 137
34. S. Naveau, V. Giraud, E. Borotto Excess weight risk factor for alcoholic liver disease Hepatology 25 1997 108 111
35. T. Poynard, S. Naveau, M. Doffoel Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls 5-year survival J Hepatol 30 1999 1130 1137
36. P. Bedossa, T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289 293
37. P. Bedossa, T. Poynard, S. Naveau Observer variation in assessment of liver biopsies of alcoholic patients Alcohol Clin Exp Res 12 1988 173 178
38. T. Poynard, P. Mathurin, C.L. Lai A comparison of fibrosis progression in chronic liver diseases J Hepatol 38 2003 257 265
39. J.L. Hintze NCSS 2003 User Guide Number Cruncher Statistical Systems 2003 software NCSS 2003 Kaysville UT
40. J.A. Hanley, B.J. McNeil A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 148 1983 839 843
41. T. Poynard, F. Imbert-Bismut, M. Munteanu Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV-Fibrosure) and necrosis (ActiTest) in patients with chronic hepatitis C Comp Hepatol 3 2004 8
42. T. Poynard, A. Abella, J.P. Pignon Apolipoprotein AI and alcoholic liver disease Hepatology 6 1986 1391 1395
43. P. Bedossa, T. Poynard, A. Abella Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patients Alcohol Clin Exp Res 13 1989 829 833
44. T. Poynard, P. Bedossa, P. Mathurin Apolipoprotein A1 and hepatic fibrosis J Hepatol 22 1995 107 110
45. V. Paradis, A. Laurent, P. Mathurin Role of liver extracellular matrix in transcriptional and post-transcriptional regulation of apolipoprotein A-I by hepatocytes Cell Mol Biol 42 1996 525 534
46. V. Paradis, P. Mathurin, V. Ratziu Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrix Hepatology 23 1996 1232 1238
47. P. Mathurin, D. Vidaud, M. Vidaud Quantification of apolipoprotein A-I and B messenger RNA in heavy drinkers according to liver disease Hepatology 23 1996 44 51
48. C. Aube, F. Oberti, N. Korali Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis J Hepatol 30 1999 472 478
49. M. Tsutsumi, S. Urashima, S. Takase Characteristics of serum hyaluronate concentrations in patients with alcoholic liver disease Alcohol Clin Exp Res 21 1997 1716 1721
50. F. Stickel, B. Hoehn, D. Schuppan Review article nutritional therapy in alcoholic liver disease Aliment Pharmacol Ther 18 2003 357 373
51. D. Labayle, J.C. Chaput, F. Albuisson Analyse histologique comparative des biopsies du lobe droit et du lobe gauche dans les lésions alcooliques du foie Gastroenterol Clin Biol 3 1979 235 240
52. P. Bedossa, D. Dargère, V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457
53. A.A. Bravo, S.G. Sheth, S. Chopra Liver biopsy N Engl J Med 344 2001 495 500